ALLIANCE A051701

Primary Category:

Treatment Protocols

Disease Category:

Diffuse Large B-cell Lymphoma, Lymphoma, Non-Hodgkin Lymphoma

Status:

Open

Randomized Phase II/III Study of Venetoclax (ABT199) Plus Chemoimmunotherapy for MYC/BCL2 Double-Hit and Double Expressing Lymphomas

NCT#03984448

Effective 09/28/20, accrual of patients of all ages with double hit lymphoma (DHL) is temporarily halted.